Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects.
about
Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).Evaluation of pharmacokinetic and pharmacodynamic interactions when lenalidomide is co-administered with warfarin in a randomized clinical trial setting.
P2860
Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Absence of pharmacokinetic and ...... warfarin in healthy subjects.
@en
type
label
Absence of pharmacokinetic and ...... warfarin in healthy subjects.
@en
prefLabel
Absence of pharmacokinetic and ...... warfarin in healthy subjects.
@en
P2860
P1433
P1476
Absence of pharmacokinetic and ...... warfarin in healthy subjects.
@en
P2093
Jasper Dingemanse
Petra Hoever
P2860
P304
P356
10.1007/S40268-013-0017-5
P577
2013-06-01T00:00:00Z